(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid

FLR as a free ligand exists in 2 entries. Examples include: 3R94 3RR3

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
Identifiers(2R)-2-(3-fluoro-4-phenyl-phenyl)propanoic acid
FormulaC15 H13 F O2
Molecular Weight244.26
Isomeric SMILESC[C@@H](C(O)=O)c1ccc(c(F)c1)-c1ccccc1

Chemical Details

Formal Charge0
Atom Count31
Chiral Atom Count1
Chiral AtomsC12
Bond Count32
Aromatic Bond Count13
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB05289 Different stereochemistry
DescriptionFLURIZAN tarenflurbil is an investigational drug being studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid plaque development in the brains of Alzheimer's disease patients.
Brand NamesFlurizan
IndicationInvestigated for use/treatment in alzheimer's disease and prostate cancer.
Mechanism of actionMPC-7869 is not an inhibitor of cyclooxygenase enzymes (COX-1 and COX-2). The compound modulates the signal transduction and transcription activation pathways associated with nuclear factor kappaB (NFkappaB), a principle transcription factor in the expression of many molecules involved in cell growth, cell death and inflammation. In addition, MPC-7869 has recently been shown to modulate gamma-secretase and selectively lower levels of Abeta42 peptide in vitro and in vivo, and to reduce amyloid pathology in the brain. MPC-7869 has an excellent safety profile and is very potent in animal models of cancer and Alzheimer's disease. In transgenic mouse studies, MPC-7869 reduced brain amyloid levels and prevented memory loss.
  • Acids, Acyclic
  • Benzene Derivatives
  • Biphenyl Compounds
  • Carboxylic Acids
  • Fatty Acids

Drug Targets

NameSequence SearchPharmacological ActionActions
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682